Squarepoint’s Biohaven Pharmaceutical Holding BHVN Stock Holding History
Bought
Maintained
Sold
Other funds holding BHVN
Squarepoint's BHVN Position: Q3 2022 in Review
Squarepoint sold out of Biohaven Pharmaceutical Holding (BHVN) in Q3 2022, closing a stake of 10,230 shares — an estimated $1.49M sold.
Squarepoint first reported a position in BHVN in Q4 2017 and held it in 15 quarters. The position peaked at $4.19M in Q1 2019. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.
- Squarepoint reported no remaining Biohaven Pharmaceutical Holding position as of Q3 2022 after selling out during the quarter.
- Squarepoint sold 10,230 Biohaven Pharmaceutical Holding shares in Q3 2022, an estimated $1.49M.
- Squarepoint first reported a position in Biohaven Pharmaceutical Holding in Q4 2017 and held it in 15 quarters.
- Squarepoint's Biohaven Pharmaceutical Holding position peaked at $4.19M in Q1 2019.
- 240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding as of Q3 2022.
Based on Squarepoint's 13F filing for Q3 2022, filed 14 Nov 2022.